Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2015 by University of California, San Francisco
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Rahul Aggarwal, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01594918
First received: May 7, 2012
Last updated: January 13, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)